Oral CGRP receptor antagonists have been found effective and well-tolerated for acute treatment of migraine [236], and CGRP and other paracrine secretions from nociceptors are thought to perhaps initiate many of the local features of CRPS, so these type drugs should be assessed for CRPS in the future. The gene discussed is CALCA; the disease is complex regional pain syndrome.